In conclusion, this pilot registry study suggests that 'primary' (idiopathic) sarcopenia can be reduced in otherwise healthy subjects with supplementation of Robuvit®. Robuvit® increased hand strength, muscular vascularization, subjective vigor and reduced plasma oxidative stress and urinary excretion of 3-methylhistidine a marker of muscle loss after 3 months.
BELCARO et al. (2026) studied this question.